Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fresenius Kabi USA LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013548
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable and specialty pharmaceutical products, transfusion technologies, parenteral nutrition and enteral nutrition. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Fresenius Kabi USA LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2011 to YTD 2017 9
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 11
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 12
Licensing Agreements 13
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 13
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 14
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 15
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 16
Fresenius Kabi USA LLC – Key Competitors 17
Fresenius Kabi USA LLC – Key Employees 18
Fresenius Kabi USA LLC – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Strategy And Business Planning 21
Nov 21, 2017: Fresenius Kabi to Expand Pharmaceutical Manufacturing in North Carolina 21
Sep 21, 2017: Fresenius Kabi breaks ground for $250 million manufacturing campus in Chicago 23
Legal and Regulatory 24
Apr 13, 2017: Fresenius Kabi Files Amicus Brief in Arkansas 24
Government and Public Interest 25
Nov 17, 2017: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls 25
Product News 27
Aug 18, 2016: Fresenius Kabi Launches Smoflipid in the United States 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Key Facts 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fresenius Kabi USA LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2011 to YTD 2017 9
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 11
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 12
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 13
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 14
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 15
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 16
Fresenius Kabi USA LLC, Key Competitors 17
Fresenius Kabi USA LLC, Key Employees 18
Fresenius Kabi USA LLC, Other Locations 19
Fresenius Kabi USA LLC, Subsidiaries 19

★海外企業調査レポート[Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bechtel Corporation:電力:M&Aディール及び事業提携情報
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, infrastructure, communications, mining and metals, oil and gas, chemicals, water, defense and nuclear, and governme …
  • Tap Oil Ltd (TAP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tap Oil Ltd (Tap Oil) is an oil and gas company that offers exploration, development and production of oil and natural gas interests. The company holds interests in Manora oil field in the Gulf of Thailand and holds a number of exploration and production permits in Australia’s Carnarvon Basi …
  • FUDAN University-製薬・医療分野:企業M&A・提携分析
    Summary FUDAN University (FUDAN) is an educational university that offers bachelor, undergraduate, master and doctoral degrees in various disciplines. The university confers bachelor's degrees in multiple academic disciplines. It conducts research in various disciplines such as natural sciences, dep …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Guerbet SA (GBT):企業の財務・戦略的SWOT分析
    Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Enagas SA (ENG):石油・ガス:M&Aディール及び事業提携情報
    Summary Enagas SA (Enagas) is a midstream company. It develops, operates, and maintains gas infrastructure; and operates and maintains gas networks. The company transports natural gas to distribution points. It is the technical manager of the Spanish gas system. Enagas is the technical manager of th …
  • Fortum Corporation (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • PT Dahana:企業の戦略・SWOT・財務情報
    PT Dahana - Strategy, SWOT and Corporate Finance Report Summary PT Dahana - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Breville Group Ltd (BRG):企業の財務・戦略的SWOT分析
    Breville Group Ltd (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ferrovial, S.A.:企業の戦略・SWOT・財務分析
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Can-Fite BioPharma Ltd (CANF):製薬・医療:M&Aディール及び事業提携情報
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that offers pharmaceutical discovery and clinical development services. The company's pipeline product portfolio includes CF101, CF102 and CF602. It develops its products by utilizing its platform technology based on the Gi pro …
  • Monopar Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The company’s pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. …
  • Umicore SA:企業の戦略・SWOT・財務情報
    Umicore SA - Strategy, SWOT and Corporate Finance Report Summary Umicore SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ricoh Co Ltd (7752):企業の財務・戦略的SWOT分析
    Ricoh Co Ltd (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sonoro Energy Ltd (SNV):石油・ガス:M&Aディール及び事業提携情報
    Summary Sonoro Energy Ltd (Sonoro Energy), formerly Sonic Technology Solutions Inc is an oil and gas company that explores, develops and produces asphalt and bitumen resources. It operates Budong Budong Production Sharing Contract on the coast of western Sulawesi, opposite to Balikpapan that offers …
  • Athersys Inc (ATHX):製薬・医療:M&Aディール及び事業提携情報
    Summary Athersys Inc (Athersys) is a biotechnology company that discovers and develops of novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as ca …
  • Chiyoda Corporation:企業の戦略・SWOT・財務分析
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Promore Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Promore Pharma AB (Promore), formerly Pergamum AB is a biopharmaceutical company that develops peptide-based product candidates for local and topical treatment of infections and wounds. The company’s pipeline products include LL-37 and PXL01 therapeutic peptides. Its PXL01 is used for the pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆